May 2026
📣 VC round data is live. Check it out!
Largest Asset Management Public Companies in Taiwan
Benchmark revenue and EBITDA valuation multiples for public comps like
Yuanta Financial Holdings, Mega Financial Holding, KGI Financial, Taiwan Cooperative Bank and Diamond Biofund.
 | Yuanta Financial Holdings Co Ltd is engages in the business of a financial holding company and its operations are limited to investing and investment management. | $2 | +83% | $25B | $19B | 4.7x | 11.8x | ||
| Mega Financial Holding Co Ltd is a financial services holding company operating mostly in Taiwan but with exposure internationally. The activities of the company includes banking, underwriting securities, brokerage and proprietary business of bills and bonds, insurance, asset management, venture capital, business operations, and others. | $1 | +3% | $20B | $23B | 9.0x | - | ||
| KGI Financial Holding Co Ltd is engages in financial holding, invests in and manages the businesses of finance-related institutions domestic and foreign approved by authorities and investees. It operates four segments: Commercial banking, Securities, Venture Capital and Insurance. Commercial banking engaged in consumer banking, corporate banking and market and financial institution. Securities engaged in wealth management business, trading business and investment banking business. Venture Capital engaged in investment business directly. Insurance department operates life insurance business based on the provisions of the insurance law. Key revenue is generated from Insurance segment. | $1 | +61% | $13B | $19B | 7.9x | - | ||
| Taiwan Cooperative Financial Holding Co Ltd is a financial holding company with a broad range of financial products and services in Taiwan. The company reportable segments include TCB business segment which includes deposit and loan, capital, trust, and other business and Other noncore business segments. The company generates maximum revenue from TCB Business segment. The company offers commercial banking, bills finance, credit cards, insurance, security and futures trading, venture capital, and asset management through its subsidiaries. | $1 | -2% | $12B | $16B | 6.6x | - | ||
| Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology. | $0 | -34% | $359M | $238M | - | - | ||
| Median | $1 | +3% | $13B | $19B | 7.3x | 11.8x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.